We are a biotechnology company specializing in the design and production of superior biological molecules targeting underrepresented human infectious diseases
VHFC participated by invitation in WHO’s R&D roadmaps on Ebola/Marburg and Lassa aimed at "identifying the vision, strategic goals, and priority research areas and activities aimed at developing effective diagnostics, therapeutic agents, and vaccines for the involved pathogen"
'Professor Jonathan Heeney
Cambridge University scientists are set to trial a new vaccine designed to counter killer diseases such as Ebola, Marburg and Lassa Fever."... https://t.co/qfX05gZfwm
'Professor Jonathan Heeney
Cambridge University scientists are set to trial a new vaccine designed to counter killer diseases such as Ebola, Marburg and Lassa Fever."
https://t.co/N2MCcVftz4
VHFC Reboot meeting, La Jolla, CA, Sept 11, 2018. Participation from VHFC and CViSB members, from many locations, several countries, a few continents, one mission...
Dr. Robert Garry of @TulaneMed is a featured speaker at tonight's #OnlyTheAudaciousATL event. Dr. Garry was instrumental in securing $12 million in grants to test drug treatments against Lassa fever. Follow along tonight to learn more about his research.
https://t.co/uR31Epqix7